Cocrystal Pharma, Inc. – Product Pipeline Review

Global Markets Direct’s, ‘Cocrystal Pharma, Inc. – Product Pipeline Review – 2016’, provides an overview of the Cocrystal Pharma, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Cocrystal Pharma, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Cocrystal Pharma, Inc.

The report provides overview of Cocrystal Pharma, Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Cocrystal Pharma, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Cocrystal Pharma, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Cocrystal Pharma, Inc.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Cocrystal Pharma, Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Cocrystal Pharma, Inc.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Cocrystal Pharma, Inc. Snapshot 6

Cocrystal Pharma, Inc. Overview 6

Key Information 6

Key Facts 6

Cocrystal Pharma, Inc. - Research and Development Overview 7

Key Therapeutic Areas 7

Cocrystal Pharma, Inc. - Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products - Monotherapy 11

Pipeline Products - Out-Licensed Products 12

Out-Licensed Products/Combination Treatment Modalities 13

Cocrystal Pharma, Inc. - Pipeline Products Glance 14

Cocrystal Pharma, Inc. - Clinical Stage Pipeline Products 14

Phase I Products/Combination Treatment Modalities 14

Cocrystal Pharma, Inc. - Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Discovery Products/Combination Treatment Modalities 16

Cocrystal Pharma, Inc. - Drug Profiles 17

CC-31244 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

CC-1845 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

CC-2068 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

CC-2069 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

CDI-244 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Gene Therapy for Hepatitis B and Human Papilloma Virus Infections 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

CC-31326 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

RS-1137 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

RS-1142 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

RS-1145 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

RS-930 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

RS-961 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

Small Molecule for Hepatitis C 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Small Molecules to Inhibit PB2 for Influenza 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Small Molecules to Inhibit RNA Dependent RNA Polymerase for Common Cold 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Small Molecules to Inhibit RNA Dependent RNA Polymerase for Dengue Virus Infections 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

Small Molecules to Inhibit RNA Dependent RNA Polymerase for Norovirus Infections 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

Cocrystal Pharma, Inc. - Pipeline Analysis 34

Cocrystal Pharma, Inc. - Pipeline Products by Target 34

Cocrystal Pharma, Inc. - Pipeline Products by Route of Administration 35

Cocrystal Pharma, Inc. - Pipeline Products by Molecule Type 36

Cocrystal Pharma, Inc. - Pipeline Products by Mechanism of Action 37

Cocrystal Pharma, Inc. - Recent Pipeline Updates 38

Cocrystal Pharma, Inc. - Dormant Projects 41

Cocrystal Pharma, Inc. - Locations And Subsidiaries 42

Head Office 42

Other Locations & Subsidiaries 42

Appendix 43

Methodology 43

Coverage 43

Secondary Research 43

Primary Research 43

Expert Panel Validation 43

Contact Us 43

Disclaimer 44

List of Tables

List of Tables

Cocrystal Pharma, Inc., Key Information 6

Cocrystal Pharma, Inc., Key Facts 6

Cocrystal Pharma, Inc. – Pipeline by Indication, 2016 8

Cocrystal Pharma, Inc. – Pipeline by Stage of Development, 2016 10

Cocrystal Pharma, Inc. – Monotherapy Products in Pipeline, 2016 11

Cocrystal Pharma, Inc. – Out-Licensed Products in Pipeline, 2016 12

Cocrystal Pharma, Inc. – Out-Licensed Products/ Combination Treatment Modalities, 2016 13

Cocrystal Pharma, Inc. – Phase I, 2016 14

Cocrystal Pharma, Inc. – Preclinical, 2016 15

Cocrystal Pharma, Inc. – Discovery, 2016 16

Cocrystal Pharma, Inc. – Pipeline by Target, 2016 34

Cocrystal Pharma, Inc. – Pipeline by Route of Administration, 2016 35

Cocrystal Pharma, Inc. – Pipeline by Molecule Type, 2016 36

Cocrystal Pharma, Inc. – Pipeline Products by Mechanism of Action, 2016 37

Cocrystal Pharma, Inc. – Recent Pipeline Updates, 2016 38

Cocrystal Pharma, Inc. – Dormant Developmental Projects,2016 41

Cocrystal Pharma, Inc., Other Locations 42

List of Figures

List of Figures

Cocrystal Pharma, Inc. – Pipeline by Indication, 2016 8

Cocrystal Pharma, Inc. – Pipeline by Stage of Development, 2016 10

Cocrystal Pharma, Inc. – Monotherapy Products in Pipeline, 2016 11

Cocrystal Pharma, Inc. – Pipeline by Target, 2016 34

Cocrystal Pharma, Inc. – Pipeline by Route of Administration, 2016 35

Cocrystal Pharma, Inc. – Pipeline by Molecule Type, 2016 36

Cocrystal Pharma, Inc. – Pipeline Products by Mechanism of Action, 2016 37

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports